0001104659-21-144009.txt : 20211126
0001104659-21-144009.hdr.sgml : 20211126
20211126170105
ACCESSION NUMBER: 0001104659-21-144009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211123
FILED AS OF DATE: 20211126
DATE AS OF CHANGE: 20211126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamstein Joshua R
CENTRAL INDEX KEY: 0001665280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39788
FILM NUMBER: 211452215
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE
STREET 2: SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER NAME:
FORMER CONFORMED NAME: Lamstein Joshua R Aklog
DATE OF NAME CHANGE: 20160128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scopus BioPharma Inc.
CENTRAL INDEX KEY: 0001772028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821248020
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: (212) 479-2513
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: Scopus Biopharma Inc.
DATE OF NAME CHANGE: 20190327
4
1
tm2133885-1_4.xml
FORM 4
X0306
4
2021-11-23
0
0001772028
Scopus BioPharma Inc.
SCPS
0001665280
Lamstein Joshua R
C/O SCOPUS BIOPHARMA INC.
420 LEXINGTON AVENUE, SUITE 300
NEW YORK
NY
10170
1
1
1
0
Chairman
W Warrants
4
2021-11-23
4
J
0
3000000
D
2021-10-01
2026-09-30
B Unit
3000000
0
I
HCFP/Capital Partners 18B-2 LLC
The Reporting Person is a member and co-manager of HCFP/Capital Partners 18B-2 LLC ("HCFP 18B-2"). On November 23, 2021, HCFP 18B-2, pursuant to a Warrant Contribution Agreement by and between the Issuer and HCFP 18B-2, agreed to contribute its 3,000,000 W Warrants back to the Company in exchange for the Company cancelling a $1.5 million contingent promissory note, including any and all interest, owed by HCFP 18B-2 to the Company.
/s/ Joshua R. Lamstein
2021-11-26